ANCA-associated vasculitis (GPA / EGPA / MPA)
Vasculitis / immunity · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Management
- Suspect a small-vessel vasculitis with the PULMONARY–RENAL syndrome (haemoptysis/alveolar haemorrhage + acute kidney injury with an active urinary sediment), mononeuritis multiplex, or multisystem constitutional illness
- Pattern-recognise: GPA (granulomatosis with polyangiitis) — ENT disease (epistaxis, sinusitis, saddle nose), lung nodules, PR3/c-ANCA; MPA (microscopic polyangiitis) — RPGN, MPO/p-ANCA; EGPA (eosinophilic granulomatosis with polyangiitis) — asthma, eosinophilia, MPO/p-ANCA
- Investigate urgently: urinalysis + microscopy (red-cell casts), U&E, FBC (eosinophils), CRP, ANCA (PR3/MPO), CXR/CT chest, and a renal biopsy for rapidly progressive glomerulonephritis
- Severe/organ-threatening disease (RPGN, pulmonary haemorrhage) is a medical emergency: high-dose corticosteroid PLUS cyclophosphamide or rituximab, and consider PLASMA EXCHANGE for pulmonary haemorrhage or severe renal failure
- Support the failing organ: oxygen/ventilation and transfusion for alveolar haemorrhage; dialysis for renal failure; treat and exclude infection (a key mimic and a risk of immunosuppression)
- Involve rheumatology/nephrology/respiratory early; anti-GBM (Goodpasture) can coexist — send anti-GBM antibodies too
Drugs & doses
High-dose corticosteroid (IV methylprednisolone)
Cyclophosphamide OR rituximab (induction)
Plasma exchange (pulmonary haemorrhage / severe renal)
Co-trimoxazole (PJP prophylaxis / GPA)
Dialysis / ventilatory support as needed
Disposition
Admit; organ-threatening disease → HDU/ICU with nephrology + rheumatology ± respiratory. Time-critical to preserve renal function and life.
Haemoptysis + AKI + haematuria = a pulmonary–renal syndrome until proven otherwise — send ANCA AND anti-GBM the same day and get nephrology involved; a rapidly rising creatinine here can become dialysis-dependent within days.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.